Aceto reported 208.73M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acasti Pharma ACST:US C$ 50.94M 39.39M
Aceto ACET:US 208.73M 12.94M
Agile Therapeutics AGRX:US $ 26.12M 9.65M
Glaxosmithkline GSK:US $ 3503M 1254M
Idera Pharmaceuticals IDRA:US $ 40.59M 3.95M
Novartis NVS:US $ 5117M 1316M
Pain Therapeutics PTIE:US $ 278.25M 3.94M
Prestige Brands PBH:US $ 163.62M 131.32M
Quaker Chemical KWR:US $ 145.61M 17.84M